Author:
Nakagawa K, ,Tada H,Akashi A,Yasumitsu T,Iuchi K,Taki T,Kodama K
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Basaki Y, Chikahisa L, Aoyagi K, Miyadera K, Yonekura K, Hashimoto A, Okabe S, Wierzba K, Yamada Y (2001) Gamma-hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Angiogenesis 4: 163–173
2. Bellotti M, Elsner B, Paez De Lima A, Esteva H, Marchevsky AM (1997) Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung. Mod Pathol 10: 1221–1227
3. Endo C, Saito Y, Iwanami H, Tsushima T, Imai T, Kawamura M, Kondo T, Koike K, Handa M, Kanno R, Fujimura S (2003) A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. Lung Cancer 40: 181–186
4. Freedman LS (1982) Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1: 121–129
5. Fujino S, Enokibori T, Tezuka N, Asada Y, Inoue S, Kato H, Mori A (1996) A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. Eur J Cancer 32A: 2070–2074
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献